Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA · Firm: MONUMENT ADVOCACY
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA · Firm: MONUMENT ADVOCACY
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Source: Senate LDA
| FRED HUTCHINSON CANCER CENTER (FORMERLY KNOWN AS SEATTLE CANCER CARE ALLIANCE) |
| 2 |
| 2026 |
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA · Firm: MONUMENT ADVOCACY
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA · Firm: MONUMENT ADVOCACY
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Issues related to insurance agent and broker fees in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH INNOVATION ALLIANCE via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services; Issues related to the use of artificial intelligence in health care.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
FIRST PRINCIPLES STRATEGIES LLC ON BEHALF OF BRUIN BIOMETRICS via MONUMENT ADVOCACY
2026 · third_quarter · 3T
Issues related to the FY 2027 Inpatient Prospective Payment System
Filing targets: Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB)
2026 · third_quarter · Q3
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · third_quarter · Q3
Issues related to health data exchange, interoperability, and data standards.
Issues related to the Medicare Physician Fee Schedule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FIRST PRINCIPLES STRATEGIES LLC ON BEHALF OF BRUIN BIOMETRICS via MONUMENT ADVOCACY
2026 · second_quarter · RR
Issues related to the FY 2027 Inpatient Prospective Payment System.
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to insurance agent and broker fees in Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH INNOVATION ALLIANCE via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services; Issues related to the use of artificial intelligence in health care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
FRED HUTCHINSON CANCER CENTER (FORMERLY KNOWN AS SEATTLE CANCER CARE ALLIANCE) via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to telehealth, PPS exemption, NIH funding, cancer prevention, healthcare workforce, and site neutrality.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · second_quarter · Q2
Issues related to health data exchange, interoperability, data standards, and Medicare Physician Fee Schedule.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to insurance agent and broker fees in Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH INNOVATION ALLIANCE via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related to health data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealth services, including mental and behavioral health services; Issues related to the use of artificial intelligence in health care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Q1
H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to health data exchange, interoperability, and data standards
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRED HUTCHINSON CANCER CENTER (FORMERLY KNOWN AS SEATTLE CANCER CARE ALLIANCE) via MONUMENT ADVOCACY
2026 · first_quarter · Q1
Issues related to telehealth, PPS exemption, NIH funding, cancer prevention, healthcare workforce, and site neutrality.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
INTEGRITY MARKETING GROUP via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues related to insurance agent and broker fees in Medicare.
HEALTH INNOVATION ALLIANCE via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues related to health data privacy and security, patient access to data, real-time benefit tools, and clinical decision support software; Issues related tohealth data interoperability, standards, information blocking, and the access, exchange, and use of health data; access to and coverage of telehealthservices, including mental and behavioral health services; Issues related to the use of artificial intelligence in health care.
2026 · first_quarter · RR
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
ATHENAHEALTH, INC. via MONUMENT ADVOCACY
2026 · first_quarter · RR
Issues related to health data exchange, interoperability, and data standards.